CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 234 participants.

Also called NCT01877746

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 234 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01877746
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Czechia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01877746. Randomized; no masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2015-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial)
Condition
Inflammatory Cardiomyopathy
Intervention (Drug)
Combination of prednisone and azathioprine
Intervention (Drug)
Combination of prednisone and azathioprine
Intervention (Other)
No intervention
Lead sponsor
St. Anne's University Hospital Brno, Czech Republic (class: other)

Record details

Record id
cardio:ct-nct01877746
Content hash
26c16c77ac6ae0805c26e938ab99c34230f74c0c6474959b03c1078fa1b52dd5